Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 6 | 13 | -1,13 % | ||
| ALTIMMUNE | 6 | - | -2,86 % | ||
| HUMACYTE | 5 | 4 | +19,23 % | ||
| KURA ONCOLOGY | 5 | 2 | -5,83 % | ||
| ATEA PHARMACEUTICALS | 5 | 1 | -12,36 % | ||
| ARBUTUS BIOPHARMA | 5 | - | +4,61 % | ||
| KYVERNA THERAPEUTICS | 5 | - | +4,30 % | ||
| ZENAS BIOPHARMA | 5 | - | +5,32 % | ||
| COMPASS PATHWAYS | 4 | 11 | +15,00 % | ||
| MIRUM PHARMACEUTICALS | 4 | 1 | -2,81 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19:12 | Replimune surges day after FDA Commissioner Makary resigns | 1 | Seeking Alpha | ||
| 19:10 | BeOne Medicines' Brukinsa TV ad 'Clarity' hit by FDA over 'misleading suggestions' | 1 | FiercePharma | ||
| 18:54 | Incyte gibt bekannt, dass mehr als 20 Abstrakte für die Präsentation auf dem Kongress der European Hematology Association (EHA) 2026 angenommen wurden | 130 | Business Wire | Daten aus der zulassungsrelevanten Phase-3-Studie "frontMIND" zur Bewertung von Tafasitamab (Monjuvi/Minjuvi) bei der Erstlinienbehandlung des diffusen großzelligen B-Zell-Lymphoms (DLBCL) wurden... ► Artikel lesen | |
| 18:12 | Autolus Therapeutics Q1 2026 Earnings Preview | 4 | Seeking Alpha | ||
| 17:31 | BTIG cuts Humacyte stock price target on revenue miss, slower ramp | 4 | Investing.com | ||
| 17:30 | Ironwood Pharma drops after CFO transition | 3 | Seeking Alpha | ||
| 17:18 | DOMA Perpetual nominates three directors to Pacira board | 2 | Investing.com | ||
| 17:06 | Invivyd Q1 2026 Earnings Preview | 2 | Seeking Alpha | ||
| 16:24 | Personalis rises as Medicare coverage for NeXT Personal test expands | 1 | Seeking Alpha | ||
| 16:22 | Cantor Fitzgerald senkt Kursziel für Harrow Health auf 88 US-Dollar wegen reduzierter Vevye-Umsatzprognose | 3 | Investing.com Deutsch | ||
| 16:18 | Cantor Fitzgerald lowers Harrow Health stock price target to $88 on Vevye revenue cut | 1 | Investing.com | ||
| 16:06 | CorMedix Q1 2026 Earnings Preview | 2 | Seeking Alpha | ||
| 15:54 | Altimmune Q1 2026 Earnings Call: Complete Transcript | 1 | Benzinga.com | ||
| 15:54 | Legend Biotech stock price target raised to $64 by RBC Capital | 2 | Investing.com | ||
| 15:48 | Tyra Biosciences GAAP EPS of -$0.64 | 2 | Seeking Alpha | ||
| 15:38 | N-Zyme Biomedical Inc.: N-Zyme Biomedical Applauds FDA's Newly Announced Initiatives Supporting Drug Repurposing for Unmet Medical Needs | 197 | ACCESS Newswire | Clinical-stage biotechnology company supports efforts to advance therapies addressing significant unmet clinical needs NEWARK, DE / ACCESS Newswire / May 13, 2026 / N-Zyme Biomedical, a clinical-stage... ► Artikel lesen | |
| 15:30 | Humacyte Reports Q1 2026 Results: Full Earnings Call Transcript | 4 | Benzinga.com | ||
| 15:14 | INSMED INC zeigt nachhaltige Stärke | 2 | Maximilian Berger | ||
| 15:06 | Kamada Q1 2026 Earnings Call: Complete Transcript | 1 | Benzinga.com | ||
| 14:54 | Gilead to present liver disease data at EASL conference | 3 | Investing.com |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.